POPULARITY
* ACLARACIONES : * Proyecto 500: * REUNIÓN DAME RUEDA JUNIO 28/29/30 Junio * FLASH: 1. Planes BMW: hasta 2026 ninguna moto eléctrica (no se venden)1. 2. CFMoto 450MT: llega en mayo la trail A2 ¡por 5990 euros!2. 3. Honda CB650 R y CBR 650 R 2024 e-Clutch: ¡qué buen invento!3. 4. SEAT dejará de comercializar los scooter MÓ 50 y 125 para centrarse en otros proyectos4. 5. Oficial: la F1 compra MotoGP, pero ¿qué significa?5. * RUMORE RUMORE: 1. CFMoto 1250 MT: ¿la KTM 1290 Adventure made in China?1 2. BMW podría estar desarrollando una gama de modelos para el carnet A2 y 500 cc * BLUFF: 1. El adiós al mito: la Honda Super Cub 50 tiene las horas contadas en el mercado japonés1. 2. Esta cruiser ofrece más autonomía que un Tesla, hasta 720 km. Así es la increíble Smartech Felo Tooz2. 3. La DGT quiere prohibir circular por las carreteras a las motos de 200 CV y endurecer el acceso al carnet A para motos de gran cilindrada3. 4. Grande-Marlaska señala el dato de las personas que van en moto en España que más le preocupa: "Supone el 25%" * 10-11 RAMÓN N “El carburador” * RUTA DE ÁLEX - Tajo internacional * BICHO RARO Aprilia rxv/sxv 450/550 * FEEDBACK * RECOMENDACIONES TIENDA: https://www.latostadora.com/shop/damerueda/?shop_trk Encuéntranos en: Instagram Dame Rueda: https://acortar.link/bqWGOu Instagram Bicho Raro: https://www.instagram.com/bichoraro_damerueda/?hl=es Instagram Diez-Once: https://www.instagram.com/diezonce_damerueda/?hl=es Facebook: https://www.facebook.com/damerueda Telegram: https://t.me/dameruedagrupo Blog Dame Rueda: https://damerueda.home.blog/ Email: Damerueda@gmail.com TikTok: https://www.tiktok.com/@damerueda?_t=8jFKY9ClhWC&_r=1 Playlist Spotify: https://open.spotify.com/playlist/3CT2H6PIfSnScSwVe3NTp5?si=WUqo6-_4Rc-EI6BdrXHciw&pi=e-XJF2dQvQRJ-p Patrocinadores: Seguros Eurolloyd, EBC FRenos, HEL Performance. Colaborador: Neumáticos Sercar de Avilés.
Soul Searching with Seneca is a part of the Walled Garden podcast network. The Walled Garden is a podcast and community by author, poet, and musician, Simon Drew, author and speaker, Sharon Lebell, and philosopher and author, Kai Whiting. To join The Walled Garden, go to thewalledgarden.com and use the promo code SENECA to get 30% off a Caretaker membership for life. Code available until July 2022. On The Walled Garden, you'll get access to over 100 unreleased episodes of Soul Searching with Seneca, and you'll have the option to attend weekly Soul Searching with Seneca meetups, as well as other exclusive events. To purchase Simon's book, The Poet & The Sage, go here: https://thewalledgarden.store/products/copy-of-the-poet-the-sage To listen to The Walled Garden Podcast, go here: https://thewalledgarden.com/the-walled-garden-podcast The reading in this episode comes from Seneca's Epistle IV. On the Terrors of Death. You can read it here: https://en.wikisource.org/wiki/Moral_letters_to_Lucilius/Letter_4
Join us on a part 3 of a 4 part podcast with Team Korea as we learn their experiences, hopes and expectations in the Teqball world. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/thefieldtalk/message Support this podcast: https://anchor.fm/thefieldtalk/support
“Memento Mori” is the phrase commonly used in Stoicism to encourage remembrance of death and of what death means in relation to our lives, and in this episode, Simon continues the discussion on Seneca's thoughts about death and learning how to die. To support the channel go to patreon.com/simonjedrew/ To get coaching with Simon go to simonjedrew.com/coaching/
This week the gang decide to spend some time sorting their inventory, garri and bear both go on solo adventures and there is an adorable scene with a bathtub! @nothingadventu1 http://Nothingadventurednothinggained.weebly.com https://www.worldanvil.com/w/talinost-snowfyre75 https://m.facebook.com/groups/373781096889023?ref=bookmarks https://www.instagram.com/nothingadventurednothinggained/
-Developing a trust in life as an antidote to fear -The difference between desiring out of lack v. abundance -Trust leading to temporary inaction until a new driving force begins to move you -Explaining my notion of God and how we came to form an intimate relationship -How trust spawns creativity and opens up possibilities we couldn't have imagined -Feeling deeply betrayed by God and releasing intense levels of sadness and anger -My injury as a final exam in unconditional love and trust
First Lenten Mission Sermon - Through Death with Christ by Very Rev. David Petras. Ss. Peter and Paul Ukrainian Catholic Church, Saskatoon, SK, Canada, March 8, 2020.
Barry & John interview Oracle Marketing Cloud Consultant Conor Hogan on the Media & Gaming industry. This is one of the most innovative industries when it comes to adopting new approaches to technology to attract consumers with annual turnovers of over $300 billion. We learn how Conor is working with customers using Oracle’s Bluekai (DMP) & Maxymiser to attract & retain users.
Welcome to the 2019 Predictive Analytics World (PAW) Conference Series. Recorded live in Las Vegas, this series is bringing interviews straight to you from exhibitors and speakers at this year’s event. In this interview, host Jamin Brazil interviews Tony Ayaz, CEO and Co-founder of Gemini Data Inc. Find Tony Online: Email: tony.ayaz@geminidata.com LinkedIn Gemini Data Inc. [00:02] Tony, when did you start Gemini? [00:03] We started the company in 2015. [00:06] 2015. We’re in the Happy Market Research Podcast right now. We’re at Predictive Analytics World and Marketing Analytics World and there’s lots of worlds in this particular conference. I think there’s like twelve. Have you guys been to this conference before? [00:19] This is actually our first time at this conference. And for us, I think it’s a win because what we’re looking for is real users with real pain a little bit beyond the typical IT folks that we’re looking for. [00:32] Got it. So, you’re based out of San Francisco. You started the business in 2015; so, you’ve had some success obviously. Tell me a little bit about what you guys do. [00:41] Sure. At Gemini Data, we help our customers with digital transformation initiatives. What I mean by that is we help customers achieve data availability. And data availability is a necessary requirement today if you’re really looking to do something significant or on digital transformation, AI, or ML initiatives. And what we mean by that is that you have to access to data and you have to make that data available. And there’s a lot of talk about out-of-the-box machine learning solutions and things that are out there in the market. But the reality is that if you’re doing complex things and trying to run your business, you need data diversity, and you only get that through data availability. And so, what we do is we leverage the customer’s existing investments in various, different data platforms: it could be in a CSV; it could be in a data lake. It doesn’t really matter to us. We have a method that we apply called Zero Copy Data Virtualization that actually takes your data that’s sourced without you to move or copy that data or do the complex ETL processes that we’ve all been used to for the past two to three decades, which just simply doesn’t scale with AI. [01:47] Data diversity is a term I’ve never heard before, but it is my favorite one in this conference. Diversity is something that we’ve... we’re becoming more and more aware, especially in the Bay Area, like Silicon Valley... I’d say globally you’re seeing... The math is that if you have more diversity in your senior leadership team, then you have a better world view, which gives you an improved advantage in the marketplace, right? [02:12] Exactly. [02:13] And what’s interesting is how you’re connecting that in with data. It isn’t about a single… right? It’s about different types of data. You mentioned CSV versus data lake, which are vastly different, like profoundly different. Your system is able to ingest both of those? [02:32] I wouldn’t say ingest, access those systems. [02:35] Got it [02:36] We don’t want you to move or copy the data, but we allow you to access it in a unified way. [02:40] OK, cool. So that bypasses some PIII? [02:42] Yes, it bypasses it in the sense that you’re giving access to people that should have access to it. So we follow the same protocols of data access they have as their role or authority would provide them. But we take it a step further of looking into five years from now, Zero Trust Networks are going to be deployed, which is a new, let’s call it, security protocol or methodology, which basically changes things versus where we’re at today: It’s the perimeter of defense, which I’m going to put firewalls around things; I’m going to give you access to things you should have; and then when ...
LDS Study Session seeks to generate reflection and about areas in the Restored Gospel. Whether it's Come Follow Me, a General Conference talk or a recent Gospel Topic, hopefully you'll find something to keep the Spirit of Christ in your life. Join me today to dive into part of this week's Come Follow Me lesson. Today we delve further into the Come Follow Me lesson for this week. Matthew 25:31-46 Elder Richard L. Evans once counseled, “We can’t do everything for everyone everywhere, but we can do something for someone somewhere.”12 [Richard Evans’ Quote Book (1971), 51.] President Howard W Hunter: Sisters, continue to seek opportunities for service. Don’t be overly concerned with status. Do you recall the counsel of the Savior regarding those who seek the “chief seats” or the “uppermost rooms”? “He that is greatest among you shall be your servant.” (Matt. 23:6, 11.) It is important to be appreciated. But our focus should be on righteousness, not recognition; on service, not status. The faithful visiting teacher, who quietly goes about her work month after month, is just as important to the work of the Lord as those who occupy what some see as more prominent positions in the Church. Visibility does not equate to value.
Prof Peter Hillmen (Leeds Teaching Hospitals NHS Trust, Leeds, UK), Prof Paolo Ghia (Università Vita-Salute San Raffaele, Milan, Italy), Dr Chris Fox (Nottingham University Hospitals NHS Trust, UK) and Dr Constantine Tam (Peter MacCallum Cancer Centre, Melbourne, Australia) discuss the latest therapeutic advances in CLL from EHA 2016. First discussed was a cross-study analysis of treatment outcomes for patients with deletion 17P CLL treated with ibrutinib. The study demonstrated a remarkably consistent RR and had not yet reached median PFS (estimated three years), which surpasses results of previous therapies for del17p CLL and is better than anything seen pre-ibrutinib. The impact of ibrutinib in relapsed/refractory CLL was analysed within a real-world setting of nearly 3000 patients across 30 countries, which suggested that results observed in ibrutinib clinical trials are reproducible in clinical practice. A key consideration surrounding the use of ibrutinib is which line of therapy to use it in, following the EMA and FDA approvals for all patients with CLL. An analysis from PIII studies showed that patients who received ibrutinib in earlier lines of treatment as 1st or 2nd line therapy were less likely to progress and experienced better post-ibrutinib survival outcomes. This reinforces the belief that ibrutinib should be used more widely in earlier lines of therapy. Also discussed were trials involving Obinutuzumab (GA101) plus chlorambucil (Clb) or rituximab (R), showing that this combination significantly increased the length of PFS in elderly populations. The panel touched upon the use of venetoclax with new data being presented at EHA, leading them to conclude that combinations of biologics may be the way forward, such as ibrutinib and venetoclax. The panel concluded the discussion by debating what should be the standard of care (SOC), suggesting that FCR should remain the SOC for young patients with no comorbidities, but all the remaining patients should benefit from novel therapies in the first line setting. This argument may be decided by ongoing trials evaluating ibrutinib versus FCR.
Prof Marivi Mateos (University Hospital of Salamanca, Salamanca, Spain), Prof Meletios Dimopoulos (University of Athens, Athens, Greece), Prof Paul Richardson (Dana-Farber Cancer Institute, Boston, USA) and Prof Phillip McCarthy (Roswell Park Cancer Institute, New York, USA) discuss the latest data on multiple myeloma from EHA 2016. Presented during the Presidential Symposium, the POLLUX data was an open-label, randomised PIII study of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM). Prof Meletios Dimopoulos outlines one of the key presentations from EHA 2016, showing a 63% reduction in the risk of progression/death and a doubling of CR for DRd vs Rd. The addition of daratumumab also increased the ORR for DRd vs Rd (93% vs 76%) and improved median PFS which was 18.4 months for patients receiving Rd and has not yet been reached in the daratumumab arm. This data led the panel to pose the question whether this could be considered “the most active treatment in this setting”, and with positive combination data also discussed from the CASTOR trial, concluding that combination therapies are having a positive impact on the MM landscape. A note of caution was expressed for triple refractory patients where combination therapy fails, so although treatment seems to be heading in the right direction, it has not yet answered some important and remaining clinical questions. Another study discussed looked at a meta-analysis of OS in patients with MM treated with lenalidomide (LEN) maintenance after high-dose melphalan and autologous stem cell transplant (ASCT). This large study demonstrated that LEN maintenance significantly prolonged OS vs placebo/no maintenance post ASCT, including in patients who achieved CR. This being the case, there are questions remaining for patients receiving this treatment with high risk genetic abnormalities. These trials show the therapeutic advances coming from EHA 2016, building anticipation for the future progress that can be made for treating patients with multiple myeloma.
Scarica il programma
Final discussion of our quarterly book selection Outwitting The Devil. The secret to Freedom and Success
Ben Harder Show E150 Oldschool Special with Maurice Steenbergen 05/07/2011 HOUR 07 Non-stop Oldschool 01. Quadrophonia - The Wave Of The Future (Medium Mix) 02. Cybersonic - Technarchy 03. Sequencial - Cycades (Reprise) 04. Modular Expansion - Cubes 05. Human Resource - Dominator (CJ Bolland Remix) 06. F.U.S.E. - Substance Abuse 07. DJ Dick - Weekend 08. Quazar - Seven Stars 09. Capella - Everybody 10. Outlander - The Vamp 11. Speedy J - Wicked Saw 12. Human Resource - 2B Free 13. Human Resource - The Joke 14. Human Resource - Dominator (Frank De Wulf #1 Mix) 15. Egma - Let The Bass Kick 16. Second Phase - Mentasm 17. D.H.s. - The House of God 18. G.T.O. - Listen To The Rythm Flow 19. Cubic 22 - Night In Motion 20. Techno Grooves - Techno Slam 21. TFO - Mekanika (Hardcore Mix) 22. Plexus - Cactus Rhythm 23. Mandroid - Oh My God It's Alive! 24. Techno Matic - It's Time To Party HOUR 08 Non-stop Oldschool 01. Sequencial - Psychotronic 02. Bizarre inc. - Plutonix 03. Felix - Dont' You Want Me 04. The Prodigy - Android 05. Science Lab - Flesh & Blood (Atmo Mix) 06. Digital Boy - This Is Mutha F**ker! 07. Channel X - Rave The Rhythm 08. CLS - Can You Feel it (In House Dub) 09. E-Dancer - Grab The Beat (Jpey Beltram Remix) 10. EMF - Masterminds 11. Voodoo Child - Voodoo Child (Contracted) 12. Set Up System - Fairy Dust (Centripetal Mix) 13. Tricky Disco - Disco 130 14. Trilithon - Children of the Future 15. 2 Fabiola - The Milkyway 16. Air of Gloom - Meditation 17. Holy Noise Presents The Global Insert Project - The Nightmare (Freddie Krueger's Message) 18. Alberto Plaza - Yo Yo 19. Frequency - Where Is Your Evidence (Club) 20. Plastikman - Spastik 21. Holy Noise Presents The Global Insert Project - H.O.U.S.E 22. F.U.S.E. Feat. Nancy Drew - From Our Minds To Yours (Intro) HOUR 09 Non-stop Oldschool 01. Channel X - Groove To Move 02. N-Joi - Manic 03. Inner Light - Phantasia 04. T99 - Nocturne (6 O'Clock Mix) 05. Cybersonik - Backlash 06. John & Julie - Double Happiness 07. T99 - Anasthasia 08. The 2 Live Crew - Me So Horny (Nasty Version) 09. Dr. Baker - Kaos 10. Public Ambient - Revival Shadow 11. N-Joi - Adrenalin 12. Misteria - Who Killed JFK 13. Tracid Posse - Power of Darkness 14. F.U.S.E. - F.U. 15. Underground Resistance - Punisher 16. Kicks Like A Mule - The Bouncer 17. 80 AUM - Mindcontroller 18. Komakino - Drill 19. The Art of Noise - Instruments of Darkness 20. L.A. Style - James Brown Is Dead
Freedom in Christ Series PIII - My Story in History [John Bond]